Auditory brainstem implant tested in children with hearing loss from missing cochleae
Tests an auditory brainstem implant in children with hearing loss and no working cochleae.
Key facts
- Who runs it
- NYU Langone Health
- Where
- New York, United StatesSee the site
- Trial code
- Registry title
- Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves
- Status
- Recruiting
- People taking part
- 20 people, planned
- Started
- May 2014
- Expected to end
- May 2030
- Type of study
- Interventional, 2 groups
- Treatments tested
- Nucleus ABI541 Auditory Brainstem Implant
- Record updated
- 28 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and young people with severe hearing loss who get no real benefit from a cochlear implant, or who have no working cochlea or hearing nerve, and who do not have NF2. They would receive an auditory brainstem implant.
- Age
- From 18 Months to 21 Years. Group 1: hearing loss from birth to 5 years, implant at 18 months to 5 years. Group 2: hearing loss after language developed, under 21 years.
- Sex
- All
- Disease stage
- Group 1: hearing loss before language developed, with an MRI or CT showing cochlear nerve deficiency, cochlear aplasia or severe hypoplasia, severe inner ear malformation, or post-meningitis ossification. Group 2: hearing loss after language developed, with loss of or no benefit from a cochlear implant (CI) that cannot be revised.
- Earlier treatment
- If a cochlea is present, no significant benefit from a cochlear implant (CI) despite consistent use for more than 6 months. Group 2 children previously developed open set speech perception and auditory-oral language skills.
Main reasons for not taking part
- Making significant progress with a cochlear implant (CI)
- MRI shows a normal cochlea and cochlear nerves, or NF2
- Clear surgical reason for poor CI results that revision or contralateral CI surgery could fix
- Intractable seizures, progressive neurological disorder, Chiari malformation, hydrocephalus or spina bifida
- Any foreseeable need for a future MRI scan, or need for brainstem irradiation
The registry criteria, word for word
Show all 26 criteriaShow less
Who can take part
- Group 1: Prelinguistic hearing loss (birth-5 years; age at implantation of ABI 18 months-5 years)
- Pre-linguistic hearing loss (birth-5 yrs.; age at ABI 18 months-5yrs) with both:
- MRI +/- CT evidence of one of the following:; Cochlear nerve deficiency; Cochlear aplasia or severe hypoplasia; Severe inner ear malformation; Post-meningitis ossification
- When a cochlea is present or patent, lack of significant benefit from CI despite consistent use (>6 mo.); No or limited speech perception ability (limited to pattern perception on closed set testing materials using the CI); Lack of progress in auditory skills development; Group 2: Post-linguistic hearing loss (<21 yrs. of age)
- Post-linguistic hearing loss (<21 yrs. of age) with:; Loss or lack of benefit from appropriate CI without the possibility for revision or contralateral implantation. Examples might include:; Post-meningitis ossification; Bilateral temporal bone fractures with cochlear nerve avulsion; Failed revision CI without benefit; Previously developed open set speech perception and auditory-oral language skills
- No medical contraindications
- Willing to receive the appropriate meningitis vaccinations
- No or limited cognitive/developmental delays
- Strong family support
- Reasonable expectations from parents/guardians including a thorough understanding:; of potential benefits and limitations of ABI; of parental role in rehabilitation; that the child may not develop spoken language as a primary communication mode or even sufficient spoken language to make significant academic progress in an aural/oral environment
- Involvement in a rehabilitation program that emphasizes development of auditory skills with or without the use of supplementary visual communication
- Able to comply with study requirements including travel to investigation sites
- Informed consent for the procedure from the child's parents/legal guardian
Who cannot take part
- Clear surgical reason for poor CI performance that can be remediated with revision CI or contralateral surgery rather than ABI
- Need for brainstem irradiation
- Intractable seizures or progressive, deteriorating neurological disorder
- Unable to tolerate general anesthesia (cardiac, pulmonary, bleeding diathesis, etc.)
- Pre- or post-linguistic child currently making significant progress with CI Even for the very young children (18 months of age with 6 months of use), nearly all children with a good auditory signal from their CI will show evidence of improvement in these metrics over time
- Unable to participate in behavioral testing and mapping with their CI. If this appears to be an age effect, ABI will be delayed until we can be assured that the child will be able to participate, as reliable objective measures of mapping are currently not available for mapping these devices
- For both Groups 1 and 2:
- MRI evidence of one of the following:; normal cochlea and cochlear nerves or NF2; brainstem or cortical anomaly that makes implantation unfeasible
- Patients with evidence of Chiari malformation, hydrocephalus, spina bifid a
- Patients with any foreseeable need for a future MRI scan
- Unrealistic expectations on the part of the subject/family regarding the possible benefits, risks and limitations inherent to the procedure and ABI device
- Unwilling to sign the informed consent
- Unwilling to make necessary follow-up appointments
Where in United States
- NYU Cochlear Implant CenterNew York, United StatesContact: Kristin MontellaTaking people
About the trial
What the trial wants to find out
This study is a feasibility study of the Nucleus 24 ABI in children without NF2. It will be conducted as a repeated-measures, single subject experiment in order to accommodate the known variability in cochlear implant clinical results. Data obtained in the course of this study will be compared with the existing published outcome data from children with normal hearing and with cochlear implants (CIs). These comparisons may provide additional useful information about the progress of ABI subjects' performance over time. Also, this may allow the results of the current study to be utilized to design future pivotal studies of the device in the pediatric population.
The 2 groups in the trial
- Pre-lingual DeafnessTreatment being tested
Surgical implantation of the Nucleus ABI541 Auditory Brainstem Implant in prelingiustically deaf children ages 18 months - 5 years
Treatment: Nucleus ABI541 Auditory Brainstem Implant
- Post-Lingual DeafnessTreatment being tested
Surgical implantation of the Nucleus ABI541 Auditory Brainstem Implant in postlinguistically deaf children \< 21 years of age
Treatment: Nucleus ABI541 Auditory Brainstem Implant
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves
- Plain-language title
- Auditory brainstem implant tested in children with hearing loss from missing cochleaeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 28 August 2026